James Eustace is a Partner in Dalberg’s Geneva office and co-leads our Global Health Practice. He has worked across the global health space providing strategic advice on issues such as product R&D, financing, policy, and program strategy.

James’ work supports decision-making in the world’s leading public health organizations. Mostly recently, he developed an approach to assessing health product preferences, and applied it in 16 low- and middle-income countries to better understand vaccine markets in the coming years. More generally, James has advised on: an infectious disease outbreak response strategy for the World Health Organization; the design and launch of a USD100m fund for the elimination of river blindness; a elimination strategy for Human African Trypanosomiasis in west and southern Africa; the creation and implementation of an R&D strategy for a non-profit vaccine developer in India, and; impact assessments of several public health interventions across malaria, TB, pandemic-influenza, and others.

James is also leading much of Dalberg’s work in the mental health space, and is passionate about shaping ideas that enhance access to care services in all countries. 

Prior to joining Dalberg, James was based in South Africa, and worked on climate change financing issues across southern Africa.